Skip to main content

and
  1. No Access

    Article

    Formulation Development, Optimization by Box-Behnken Design, and In Vitro Characterization of Gefitinib Phospholipid Complex Based Nanoemulsion Drug Delivery System

    Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that has been authorized for the treatment of non-small lung cancer; however, its applications are not restricted. Instead, it ...

    Mohit, Pankaj Kumar, Pavitra Solanki, Bharti Mangla in Journal of Pharmaceutical Innovation (2023)